Bibliography

Export 30 results:
Filters: Keyword is *cognitive defect  [Clear All Filters]
M
Maxwell C.J, Campitelli M.A, Hogan D.B, Diong C., Austin P.C, Amuah J.E, Lapane K., Seitz D.P, Gill S.S, Gruneir A. et al..  2017.  Frailty, antipsychotics and mortality among community-based older adults with impaired cognition. Pharmacoepidemiology and Drug Safety. 26(Supplement 2):456-457.
Maxwell C.J, Campitelli M.A, Hogan D.B, Diong C., Austin P.C, Amuah J.E, Lapane K., Seitz D.P, Gill S.S, Gruneir A. et al..  2017.  Frailty, antipsychotics and mortality among community-based older adults with impaired cognition. Pharmacoepidemiology and Drug Safety. 26(Supplement 2):456-457.
B
Borkent J.W, van Hout H.PJ, Feskens E.JM, Naumann E., de van der Schueren M.AE.  2022.  Behavioral and Cognitive Problems as Determinants of Malnutrition in Long-Term Care Facilities, a Cross-Sectional and Prospective Study. Journal of Nutrition, Health and Aging. 26(8):749-759.
M
Maxwell C.J, Campitelli M.A, Hogan D.B, Diong C., Austin P.C, Amuah J.E, Lapane K., Seitz D.P, Gill S.S, Gruneir A. et al..  2017.  Frailty, antipsychotics and mortality among community-based older adults with impaired cognition. Pharmacoepidemiology and Drug Safety. 26(Supplement 2):456-457.
Maxwell C.J, Campitelli M.A, Hogan D.B, Diong C., Austin P.C, Amuah J.E, Lapane K., Seitz D.P, Gill S.S, Gruneir A. et al..  2017.  Frailty, antipsychotics and mortality among community-based older adults with impaired cognition. Pharmacoepidemiology and Drug Safety. 26(Supplement 2):456-457.
B
Borkent J.W, van Hout H.PJ, Feskens E.JM, Naumann E., de van der Schueren M.AE.  2022.  Behavioral and Cognitive Problems as Determinants of Malnutrition in Long-Term Care Facilities, a Cross-Sectional and Prospective Study. Journal of Nutrition, Health and Aging. 26(8):749-759.
W
Wang S., J. Mello DAlmeida, Declercq A..  2022.  Factors associated with informal caregiver's ability to continue care: a subgroup analysis. Age and Ageing. 51(12)
M
Maxwell C.J, Campitelli M.A, Hogan D.B, Diong C., Austin P.C, Amuah J.E, Lapane K., Seitz D.P, Gill S.S, Gruneir A. et al..  2017.  Frailty, antipsychotics and mortality among community-based older adults with impaired cognition. Pharmacoepidemiology and Drug Safety. 26(Supplement 2):456-457.
B
Borkent J.W, van Hout H.PJ, Feskens E.JM, Naumann E., de van der Schueren M.AE.  2022.  Behavioral and Cognitive Problems as Determinants of Malnutrition in Long-Term Care Facilities, a Cross-Sectional and Prospective Study. Journal of Nutrition, Health and Aging. 26(8):749-759.
G
Giani T., Villani E.R, Palmer K., Onder G., Liperoti R..  2022.  Antipsychotic use and risk of death in older adults with cognitive impairment: The role of frailty. European Geriatric Medicine. 13(Supplement 1):S277-S278.
M
Maxwell C.J, Campitelli M.A, Hogan D.B, Diong C., Austin P.C, Amuah J.E, Lapane K., Seitz D.P, Gill S.S, Gruneir A. et al..  2017.  Frailty, antipsychotics and mortality among community-based older adults with impaired cognition. Pharmacoepidemiology and Drug Safety. 26(Supplement 2):456-457.
Maxwell C.J, Campitelli M.A, Hogan D.B, Diong C., Austin P.C, Amuah J.E, Lapane K., Seitz D.P, Gill S.S, Gruneir A. et al..  2017.  Frailty, antipsychotics and mortality among community-based older adults with impaired cognition. Pharmacoepidemiology and Drug Safety. 26(Supplement 2):456-457.
Maxwell C.J, Campitelli M.A, Hogan D.B, Diong C., Austin P.C, Amuah J.E, Lapane K., Seitz D.P, Gill S.S, Gruneir A. et al..  2017.  Frailty, antipsychotics and mortality among community-based older adults with impaired cognition. Pharmacoepidemiology and Drug Safety. 26(Supplement 2):456-457.
W
Wu N., Miller S.C, Lapane K., Roy J., Mor V..  2005.  Impact of cognitive function on assessments of nursing home residents' pain. Medical Care. 43(9):934-939.
M
Maxwell C.J, Campitelli M.A, Hogan D.B, Diong C., Austin P.C, Amuah J.E, Lapane K., Seitz D.P, Gill S.S, Gruneir A. et al..  2017.  Frailty, antipsychotics and mortality among community-based older adults with impaired cognition. Pharmacoepidemiology and Drug Safety. 26(Supplement 2):456-457.
G
Giani T., Villani E.R, Palmer K., Onder G., Liperoti R..  2022.  Antipsychotic use and risk of death in older adults with cognitive impairment: The role of frailty. European Geriatric Medicine. 13(Supplement 1):S277-S278.
M
Maxwell C.J, Campitelli M.A, Hogan D.B, Diong C., Austin P.C, Amuah J.E, Lapane K., Seitz D.P, Gill S.S, Gruneir A. et al..  2017.  Frailty, antipsychotics and mortality among community-based older adults with impaired cognition. Pharmacoepidemiology and Drug Safety. 26(Supplement 2):456-457.
W
Wang S., J. Mello DAlmeida, Declercq A..  2022.  Factors associated with informal caregiver's ability to continue care: a subgroup analysis. Age and Ageing. 51(12)
Wu N., Miller S.C, Lapane K., Roy J., Mor V..  2005.  Impact of cognitive function on assessments of nursing home residents' pain. Medical Care. 43(9):934-939.
Wu N., Miller S.C, Lapane K., Roy J., Mor V..  2005.  Impact of cognitive function on assessments of nursing home residents' pain. Medical Care. 43(9):934-939.
B
Borkent J.W, van Hout H.PJ, Feskens E.JM, Naumann E., de van der Schueren M.AE.  2022.  Behavioral and Cognitive Problems as Determinants of Malnutrition in Long-Term Care Facilities, a Cross-Sectional and Prospective Study. Journal of Nutrition, Health and Aging. 26(8):749-759.
G
Giani T., Villani E.R, Palmer K., Onder G., Liperoti R..  2022.  Antipsychotic use and risk of death in older adults with cognitive impairment: The role of frailty. European Geriatric Medicine. 13(Supplement 1):S277-S278.
Giani T., Villani E.R, Palmer K., Onder G., Liperoti R..  2022.  Antipsychotic use and risk of death in older adults with cognitive impairment: The role of frailty. European Geriatric Medicine. 13(Supplement 1):S277-S278.
W
Wu N., Miller S.C, Lapane K., Roy J., Mor V..  2005.  Impact of cognitive function on assessments of nursing home residents' pain. Medical Care. 43(9):934-939.
M
Maxwell C.J, Campitelli M.A, Hogan D.B, Diong C., Austin P.C, Amuah J.E, Lapane K., Seitz D.P, Gill S.S, Gruneir A. et al..  2017.  Frailty, antipsychotics and mortality among community-based older adults with impaired cognition. Pharmacoepidemiology and Drug Safety. 26(Supplement 2):456-457.